Sort   by:  
 Page size 
UnknownNew Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations.
Not available
S-EPMC9739025 | biostudies-literature
UnknownReduced Verbal Fluency following Subthalamic Deep Brain Stimulation: A Frontal-Related Cognitive Deficit?
Not available
S-EPMC4598145 | biostudies-literature
UnknownHigh IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.
Not available
S-EPMC12548205 | biostudies-literature
UnknownPerformance comparison of modified ComBat for harmonization of radiomic features for multicenter studies.
Not available
S-EPMC7314795 | biostudies-literature
UnknownTarget volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.
Not available
S-EPMC10324255 | biostudies-literature
UnknownGemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Not available
S-EPMC6372099 | biostudies-literature
UnknownSmall-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial.
Not available
S-EPMC10570918 | biostudies-literature
UnknownTACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial.
Not available
S-EPMC10017427 | biostudies-literature
UnknownRandomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Not available
S-EPMC8896060 | biostudies-literature
UnknownNationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.
Not available
S-EPMC7906477 | biostudies-literature
Sort   by:  
 Page size